"Dr. St.Claire joins PARC at an exciting time in our evolution," PARC President Mark Bernstein said. "As an independent center for innovation, we have established a successful track record helping global enterprises and early-stage startups to research and develop fundamental business and technology platforms.

"Dr. St.Claire brings technology expertise in diverse commercial domains, particularly in biomedical, pharmaceutical, and life sciences, and she knows how to exploit synergies between different markets," Bernstein continued. "Our clients will benefit from her ability to develop compelling business visions and translate them into executable plans to create and capture opportunity."

Among St.Claire’s accomplishments, she previously served as general manager and vice president of commercial operations at a healthcare subsidiary of Oxonica, Inc., where she developed and managed relationships with Fortune 500 companies, and handled transactions from origination to deal structuring, negotiations, and closure. Prior to that, she directed business development for healthcare diagnostics leader Roche, identifying, evaluating and executing new strategic partnerships, licensing deals, and acquisitions. St.Claire also has held management positions at Abbott Labs, Abaxis, and PharmChem Laboratories. She holds a PhD in chemistry from University of California at Davis, and an MBA from University of California at Berkeley.

A center for commercial innovation, PARC (Palo Alto Research Center Inc., a Xerox Company) works closely with clients to discover, test, and deliver new business opportunities. Enterprises and entrepreneurs engage PARC so they may gain new insights into customer needs, extend technical capabilities, and acquire valuable new technology assets. PARC was previously known as "Xerox PARC," then incorporated in 2002 as a wholly owned subsidiary of Xerox Corporation (NYSE:XRX). Learn how organizations work with PARC: www.parc.com/services